Interestingly, in ARID1B KO tumors, Ki67 expression was almost absent in the Niraparib‐treated group compared to the vehicle‐treated group, suggesting a significant reduction in tumor cell proliferation in response to the drug. Here, ARID1B is linked to neoplasm.